Reports

Diagnostic test products have never been more critical. Kalorama Information’s report, 2021 IVD Market Update and COVID-19 Impact, provides an updated analysis of the in vitro diagnostics (IVD) market, reflecting the latest information from our analysts. This comprehensive report includes market sizing for various IVD categories and examines the major trends and impacts of COVID-19…

In vitro diagnostic (IVD) test volumes are crucial for assessing market opportunities for new entrants with diagnostic products and beneficial for existing product marketers. Kalorama’s In Vitro Diagnostic (IVD) Procedure Volumes, 2020-2025 delivers comprehensive market analysis, saving time with detailed calculations and estimates for the current and future number of diagnostic tests across multiple categories.…

This report provides detailed data on every major life science and analytical instrument technology in the industry, enabling you and your staff to make accurate evaluations and informed decisions. Numerous vendors, distributors and investors will reference this report over the coming years as the most comprehensive and accurate source of information on the instrument industry…

The global COVID-19 pandemic has profoundly transformed the diagnostic industry, creating an unprecedented demand for test products and leading to significant market growth. Kalorama Information’s COVID-19 Testing Update, 2021: Molecular & Antigen Markets, Procedures, Mutations, Home Tests, and Other Trends report offers an in-depth analysis of this rapidly evolving market, focusing on molecular, antigen, and…

Kalorama Information’s latest report, The Market and Potential for Molecular Point of Care (mPOC), 2021, provides comprehensive market sizing, forecasting, trend mapping, and competitive analysis for point of care (POC) tests using PCR or other molecular technologies. Designed for near-patient settings, these tests offer fast turnaround times. Major in vitro diagnostic (IVD) companies such as…

Explore the comprehensive analysis of the POC testing market, its growth prospects, and the key players driving innovation in this essential segment of the healthcare industry in Kalorama Information’s report, The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 8th Edition.

By the middle of the decade, the global point-of-care (POC) testing market is expected to…

The genetic involvement in the pathogenesis of neurological diseases is profound, with central nervous system disorders accounting for about 60 percent of the 6,400 phenotypic entries in cataloged inherited human diseases. Neurological diseases, especially brain diseases, represent the final frontier in medical discovery. Advances in testing, such as next-generation sequencing (NGS), have been instrumental in…

The global academic market for analytical and life science instrumentation is enormous. Covering 17% of the $67 billion industry, it is the largest individual end market, encompassing university research labs, core labs, non-profit research institutes, and university clinical research. A bastion of basic research, academia is at the frontier of scientific discovery itself. For today’s…

Sepsis poses one of the greatest challenges in healthcare today, with approximately 1.7 million cases and 270,000 deaths annually in the United States alone. The condition is the most expensive to treat in US hospitals, highlighting the urgent need for effective diagnosis and treatment solutions. Kalorama Information’s report, Sepsis Diagnostics Products and Market Trends, provides…

This report provides an in-depth and up-to-date look into scientists’ use of the genome editing tool, CRISPR/Cas9. Our survey reveals that while the market is growing steadily, there are challenges confronting suppliers. For instance, Bioinformatics found that over a quarter of scientist respondents said they were highly or somewhat likely to switch away from their primary brand…

The Worldwide Market for Laboratory-Developed Tests (LDTs), 2nd Edition provides a comprehensive analysis of the global sequencing market. This report covers market trends, challenges, strategies, and detailed profiles of key companies and products. It includes precise market share estimates and revenue growth forecasts, offering insights into the competitive landscape, including major deals and product developments.…

Urgent care centers (UCCs) are a vital and growing segment of the U.S. healthcare system, with around 10,000 locations nationwide. They offer walk-in care, a broad range of services, extended hours, and minimal wait times. Kalorama Information’s report, The U.S. Market for Urgent Care Centers (Including COVID-19, POC Tests, Vaccines and Other Sales), 2^nd Edition,…